|
DK3143134T3
(da)
|
2014-05-15 |
2021-01-04 |
Nat Univ Singapore |
Modificerede, naturlige dræberceller og anvendelser deraf
|
|
US10813952B2
(en)
*
|
2014-11-14 |
2020-10-27 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
NK cells with an increased antibody-dependent cellular toxicity (ADCC) against tumors
|
|
US12516292B2
(en)
|
2016-07-25 |
2026-01-06 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Methods of producing modified natural killer cells and methods of use
|
|
JP7086928B2
(ja)
|
2016-07-25 |
2022-06-20 |
ザ ユナイテッド ステイツ オブ アメリカ， アズ リプレゼンテッド バイ ザ セクレタリー， デパートメント オブ ヘルス アンド ヒューマン サービシーズ |
改変されたナチュラルキラー細胞を生成する方法および使用方法
|
|
US20180344768A1
(en)
*
|
2016-12-09 |
2018-12-06 |
Onkimmune Limited |
Nk cell-based therapy
|
|
CN110546265A
(zh)
|
2017-02-09 |
2019-12-06 |
因达普塔治疗公司 |
工程化自然杀伤(nk)细胞及其组合物和方法
|
|
BR112019019917A2
(pt)
|
2017-03-27 |
2020-04-22 |
Nat Univ Singapore |
receptores quiméricos nkg2d truncados e seus usos em imunoterapia de células exterminadoras naturais
|
|
CA3056591A1
(en)
|
2017-03-27 |
2018-10-04 |
National University Of Singapore |
Stimulatory cell lines for ex vivo expansion and activation of natural killer cells
|
|
IL276365B2
(en)
|
2018-02-01 |
2023-10-01 |
Nkmax Co Ltd |
A method for the production of natural killer cells and a preparation for cancer treatment
|
|
EP3749685A4
(en)
*
|
2018-02-09 |
2021-12-22 |
National University of Singapore |
ACTIVATOR CHEMERIC RECEPTORS AND THEIR USES IN NATURAL KILLING CELL IMMUNOTHERAPY
|
|
EP3755347B1
(en)
*
|
2018-02-21 |
2025-06-25 |
Board of Regents, The University of Texas System |
Universal antigen presenting cells and uses thereof
|
|
US12473336B2
(en)
|
2018-02-21 |
2025-11-18 |
Board Of Regents, The University Of Texas System |
Methods for activation and expansion of natural killer cells and uses thereof
|
|
GB201804701D0
(en)
*
|
2018-03-23 |
2018-05-09 |
Gammadelta Therapeutics Ltd |
Lymphocytes expressing heterologous targeting constructs
|
|
JP7334985B2
(ja)
|
2018-04-02 |
2023-08-29 |
ナショナル ユニヴァーシティー オブ シンガポール |
免疫細胞で発現される膜結合抗サイトカイン非シグナル伝達バインダーによるヒトサイトカインの中和
|
|
US20210228630A1
(en)
*
|
2018-05-16 |
2021-07-29 |
Research Institute At Nationwide Children's Hospital |
Generation of knock-out primary and expanded human nk cells using cas9 ribonucleoproteins
|
|
US12269863B2
(en)
|
2018-05-23 |
2025-04-08 |
Manysmart Therapeutics, Inc. |
Bispecific T cell engager and uses thereof
|
|
KR20210016567A
(ko)
|
2018-05-30 |
2021-02-16 |
글리코스템 떼라퓨틱스 비.브이. |
Car nk 세포
|
|
WO2019232631A1
(en)
*
|
2018-06-06 |
2019-12-12 |
Stemcell Technologies Canada Inc. |
Kits, compositions and methods for myeloid-derived suppressor cell enrichment
|
|
JP7241161B2
(ja)
|
2018-08-01 |
2023-03-16 |
イミュニティーバイオ、インコーポレイテッド |
細胞免疫療法の安定した遺伝子改変のための、ホーミング受容体又はサイトカインとキメラ抗原受容体とを含むクアドリシストロニックシステム
|
|
SG11202102012SA
(en)
*
|
2018-08-28 |
2021-04-29 |
Pharos Vaccine Inc |
Improved lentiviral vector
|
|
US20210213119A1
(en)
*
|
2018-08-28 |
2021-07-15 |
Immunotech Biopharm Co., Ltd. |
Improved therapeutic t cell
|
|
EP3844186A4
(en)
|
2018-08-29 |
2022-08-17 |
National University of Singapore |
METHOD OF SPECIFIC STIMULATION OF SURVIVAL AND EXPANSION OF GENETICALLY MODIFIED IMMUNE CELLS
|
|
CN110511912B
(zh)
*
|
2018-08-30 |
2024-03-22 |
浙江煦顼技术有限公司 |
免疫细胞的功能调节
|
|
WO2020077091A1
(en)
*
|
2018-10-10 |
2020-04-16 |
Wisconsin Alumni Research Foundation |
Kir 7.1 gene therapy vectors and methods of using the same
|
|
CN109402053A
(zh)
*
|
2018-10-17 |
2019-03-01 |
广州元帅生物科技有限公司 |
一种外周血来源单个核细胞的分离及诱导培养方法
|
|
EP3884041A2
(en)
*
|
2018-11-21 |
2021-09-29 |
Indapta Therapeutics, Inc. |
Methods for expansion of natural killer (nk) cell subset and related compositions and methods
|
|
CA3120563A1
(en)
|
2018-11-26 |
2020-06-04 |
Nkarta, Inc. |
Methods for the simultaneous expansion of multiple immune cell types, related compositions and uses of same in cancer immunotherapy
|
|
EP3927730A4
(en)
|
2019-02-20 |
2022-12-21 |
Rutgers, The State University of New Jersey |
EXPANSION OF NATURAL KILLER CELLS AND CHIMERIC ANTIGEN RECEPTOR MODIFIED CELLS
|
|
EP3773918A4
(en)
|
2019-03-05 |
2022-01-05 |
Nkarta, Inc. |
CD19 DIRECTED CHIMERIC ANTIGEN RECEPTORS AND THEIR USES IN IMMUNOTHERAPY
|
|
CN113710697A
(zh)
|
2019-03-15 |
2021-11-26 |
美国政府(由卫生和人类服务部的部长所代表) |
嵌合衔接子和激酶信号传导蛋白及其在免疫疗法中的用途
|
|
KR20200110576A
(ko)
*
|
2019-03-15 |
2020-09-24 |
재단법인대구경북과학기술원 |
사이토카인 기반 면역세포 및 그의 면역 치료 용도
|
|
JP2022526504A
(ja)
*
|
2019-03-21 |
2022-05-25 |
オーエヌケー セラピューティクス リミテッド |
細胞死に対する耐性が増大した改変免疫エフェクター細胞
|
|
EP3712257A1
(en)
*
|
2019-03-21 |
2020-09-23 |
ONK Therapeutics Limited |
Modified natural killer cells with increased resistance to cell death
|
|
CN110079529A
(zh)
*
|
2019-04-28 |
2019-08-02 |
成都美杰赛尔生物科技有限公司 |
用于靶向敲除人NKG2A/KLRC1基因的sgRNA、表达载体、试剂盒及其用途
|
|
CN110106202A
(zh)
*
|
2019-05-07 |
2019-08-09 |
杭州师范大学 |
抗肿瘤nk细胞的制备方法及其细胞与应用
|
|
AU2020290969A1
(en)
*
|
2019-06-14 |
2022-02-03 |
G Tech Bio Llc |
Activated lymphocytic cells and methods of using the same to treat cancer and infectious conditions
|
|
CN110205293A
(zh)
*
|
2019-06-25 |
2019-09-06 |
中冠赛尔生物科技(北京)有限公司 |
一种加强型高效治疗肺癌的nk免疫细胞的制备方法及应用
|
|
US20220347216A1
(en)
*
|
2019-09-13 |
2022-11-03 |
Ohio State Innovation Foundation |
Nk cell immunotherapy compositions, methods of making and methods of using same
|
|
US20210077527A1
(en)
*
|
2019-09-13 |
2021-03-18 |
The Research Institute At Nationwide Children's Hospital |
Universal donor selection method to identify nk-cell-donors
|
|
US11230699B2
(en)
|
2020-01-28 |
2022-01-25 |
Immunitybio, Inc. |
Chimeric antigen receptor-modified NK-92 cells targeting EGFR super-family receptors
|
|
BR112022017512A2
(pt)
|
2020-03-26 |
2022-10-18 |
Us Health |
Receptores de antígeno quiméricos contendo domínio cd28h e métodos de uso dos mesmo
|
|
WO2022007796A1
(zh)
*
|
2020-07-06 |
2022-01-13 |
上海鑫湾生物科技有限公司 |
共表达IL-21和hrCD16嵌合受体的免疫细胞及其应用
|
|
IL300903A
(en)
*
|
2020-09-02 |
2023-04-01 |
Nkarta Inc |
Expansion and enhanced cytotoxicity of natural killer cells and their uses
|
|
EP3964265A1
(en)
*
|
2020-09-07 |
2022-03-09 |
Fundacion Instituto De Investigacion Sanitaria Fundacion Jimenez Diaz |
Mesenchymal stem cells co-expressing cxcr4 and il-10 and uses thereof
|
|
CN112029721A
(zh)
*
|
2020-09-09 |
2020-12-04 |
广东昭泰体内生物医药科技有限公司 |
一种活性增强型nk细胞的制备方法
|
|
KR102581230B1
(ko)
*
|
2020-10-16 |
2023-09-21 |
의료법인 성광의료재단 |
항암 관련 유전자 발현이 조절된 자연살해세포 및 이의 용도
|
|
WO2022098718A1
(en)
|
2020-11-04 |
2022-05-12 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Modified nk cells with reduced ccr5 expression and methods of their use
|
|
US20240197783A1
(en)
*
|
2021-04-21 |
2024-06-20 |
Indapta Therapeutics, Inc. |
Methods of treatment and dosing of natural killer cell compositions
|
|
CN115505572B
(zh)
*
|
2021-06-22 |
2025-11-14 |
康立泰生物医药(青岛)有限公司 |
一种增强型抗肿瘤nk细胞及其制备方法和应用
|
|
AU2022337186A1
(en)
*
|
2021-08-30 |
2025-03-06 |
Carrygenes Bioengineering, Llc |
Use of chemokine receptors in cellular homing
|
|
WO2023044304A1
(en)
|
2021-09-15 |
2023-03-23 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Chimeric adaptor and kinase signaling proteins and their use in immunotherapy
|
|
CN114306606B
(zh)
*
|
2021-11-29 |
2023-05-26 |
江苏省人民医院（南京医科大学第一附属医院） |
cGAS抑制剂在制备治疗T细胞淋巴瘤的药物中的应用
|
|
CN114381434A
(zh)
*
|
2022-01-17 |
2022-04-22 |
华东师范大学 |
一种趋化型car-nk细胞及其制备方法和应用
|
|
CN114807237A
(zh)
*
|
2022-05-12 |
2022-07-29 |
广东普罗凯融生物医药科技有限公司 |
一种过表达CD16a的NK细胞的制备方法及其应用
|
|
CN115074325A
(zh)
*
|
2022-07-07 |
2022-09-20 |
广州希灵生物科技有限公司 |
Herceptin联合4-1BBL体外扩增NK方法
|
|
CN115466726B
(zh)
*
|
2022-09-05 |
2023-09-19 |
北京景达生物科技有限公司 |
一种nk细胞的高效基因转导方案
|
|
CN116178566A
(zh)
*
|
2022-09-30 |
2023-05-30 |
深圳博雅感知药业有限公司 |
靶向cd33的嵌合抗原受体和制备b16-cd33 car-nk细胞的方法
|
|
CN115975922B
(zh)
*
|
2022-12-15 |
2024-06-28 |
杭州师范大学 |
Bx795在制备nk-92细胞激活剂上的应用
|
|
CN120344655A
(zh)
*
|
2022-12-19 |
2025-07-18 |
苏州沙砾生物科技有限公司 |
一种细胞培养方法及其用途
|
|
WO2024261045A1
(en)
|
2023-06-20 |
2024-12-26 |
Zelluna Immunotherapy As |
Methods of enhancing or modifying nk cells
|
|
WO2025232819A1
(en)
*
|
2024-05-08 |
2025-11-13 |
Qihan Hong Kong Limited |
Immunotherapies using engineered cells for enhanced bone marrow homing
|
|
EP4692325A1
(en)
*
|
2024-08-07 |
2026-02-11 |
Miltenyi Biotec B.V. & Co. KG |
Method for generation of a composition comprising natural killer cells
|